• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hikal Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Kalyani
  • BSE Code : 4401.0
  • ISIN : INE475B01022
317.25 -6 (-1.81%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    315.00

  • Today’s High

    330.00

  • Open

    323.00

  • Perv Close

    323.10

  • 52W Low

    309.15

  • 52W High

    464.75

Key Indicators

  • P/E(TTM)

    43.04

  • Mar.Cap (₹Cr.)

    3,911.72

  • Div & Yield %

    0.44

  • Book Value(₹)

    102.36

  • Debt-Equity Ratio

    -1.81

  • AGM Date

    01-Aug-2025

  • EPS

    7.37

  • P/E Ratio

    43.04

Financials Ratios

  • Debt-Equity Ratio

    0.67

  • Mar.Cap (₹Cr.)

    3,911.72

  • RONW (%)

    6.00

  • ROCE (%)

    7.51

Score Board

  • Equity (₹ in Cr.)

    24.66

  • BV (₹)

    102.40

  • Sales( ₹ in Cr.)

    1,843.50

  • NP (in Cr.)

    90.90

  • NP Var(%)

    31.0

  • Div%

    70.0

  • CPS (₹)

    18.30

  • EPS (₹)

    7.40

  • Traded Value (₹ in Lakhs)

    3,911.10

  • 52 Week High

    464.75

  • 52 Week Low

    309.15

  • Price BSE

    317.0

  • Price NSE

    317.00

  • Market Capital( in Cr.)

    3,911.10

  • P/C Ratio

    17.30

  • P/E Ratio

    43.00

  • Price Vs.BV

    7.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,784.60 2,023.03 1,942.72 1,720.44 1,507.26 1,589.61
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,784.60 2,023.03 1,942.72 1,720.44 1,507.26 1,589.61
Other Income 2.45 5.41 4.89 4.98 3.70 2.26
Stock Adjustments -19.51 14.56 35.82 -1.67 5.58 14.98
Total Income 1,767.54 2,043.00 1,983.43 1,723.75 1,516.54 1,606.85
EXPENDITURE :            
Raw Materials 805.15 1,121.59 1,032.21 906.71 781.90 868.80
Power and Fuel Cost 170.16 186.91 175.46 147.83 129.99 132.04
Employee Cost 243.98 220.40 201.35 164.32 156.57 135.69
Other Manufacturing Expenses 136.52 114.60 106.37 91.27 93.71 90.24
Selling and Administration Expenses 116.24 110.01 101.31 64.05 55.56 52.50
Miscellaneous Expenses 26.10 27.02 21.28 21.71 37.35 27.19
Employee Benefit Expenses 243.98 220.40 201.35 164.32 156.57 135.69
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,498.14 1,780.53 1,637.98 1,395.88 1,255.08 1,306.46
Operating Profit 269.40 262.47 345.46 327.87 261.46 300.40
Interest 56.37 48.10 31.22 36.20 52.42 58.43
Gross Profit 213.03 214.37 314.24 291.67 209.04 241.97
Depreciation 117.61 109.01 95.67 85.25 82.46 92.88
Profit Before Tax 95.42 105.36 218.57 206.42 126.58 149.09
Current Tax 28.37 30.48 59.65 79.55 34.70 45.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.47 -3.49 -1.59 -6.27 7.44 0.51
Reported Net Profit 69.51 78.38 160.51 133.14 84.44 103.08
Extraordinary Items 0.37 0.45 0.14 0.01 -10.36 -0.02
Adjusted Net Profit 69.14 77.93 160.37 133.13 94.80 103.10
Adjustment below Net Profit -0.65 -0.60 1.19 -1.44 -4.19 -2.65
P & L Balance brought forward 870.05 804.60 670.03 553.12 492.61 405.75
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 14.80 12.33 27.13 14.80 19.73 13.56
P & L Balance carried down 924.11 870.05 804.60 670.03 553.12 492.61
Dividend 0.00 0.00 0.00 2.47 12.33 7.40
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 60.00 60.00 80.00 100.00 60.00 60.00
Dividend Per Share(Rs) 1.20 1.20 1.60 2.00 1.20 1.20
Earnings Per Share-Unit Curr 5.64 6.36 13.02 10.80 6.85 8.36
Earnings Per Share(Adj)-Unit Curr 5.64 6.36 13.02 10.80 6.85 8.36
Book Value 96.32 91.93 86.62 75.70 66.22 61.33
Book Value(Adj)-Unit Curr 96.32 91.93 86.62 75.70 66.22 61.33

Shareholding Pattern

  • Promoter Group

    68.85%

  • Public Share Holding

    31.15%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 72,172,664 58.53 72,172,664 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 12,082,600 9.80 12,082,600 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 637,500 0.52 637,500 7
Others 0 0.00 0 0
Sub Total 84,892,764 68.85 84,892,764 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 250 0.00 250 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 6,603,752 5.36 6,603,752 86
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 3,658,269 2.97 3,658,269 8
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,304,425 1.06 1,304,425 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 11,566,696 9.38 11,566,696 104
2] Non Institution
Bodies Corporate 1,972,842 1.60 1,972,842 339
Clearing Members 3,632 0.00 3,632 6
Directors of their Relatives 449,183 0.36 449,183 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,049,025 1.66 2,049,025 1,506
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,061,776 0.86 1,061,776 1,362
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,393,785 1.94 2,393,785 8
Individuals holding nominal share capital up to Rs. 1 lakh 18,263,537 14.81 18,132,575 67,985
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 18,515 0.02 18,515 2
Others 396,326 0.32 396,326 6
Sub Total 26,841,290 21.77 26,710,328 71,269
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 123,300,750 100.00 123,169,788 71,391

Company Background

Hikal LtdPharmaceuticals - Indian - Bulk Drugs

  • Hikal Ltd
  • BSE Code : 4401.0
  • ISIN : INE475B01022

  • Incorporation Year

    1988

  • Registered Office

    717/718 Maker Chamber V
    7th Floor Nariman Point, Mumbai,
    Maharashtra-400021

  • Telephone

    91-022-3926 7100/62770477

  • FAX

    91-022-2283 3913

  • Chairman

    Sameer Hiremath

  • Managing Director

    Sameer Hiremath

  • Company Secretary

    Rajasekhar Reddy

  • Auditor

    S R B C & Co LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Universal Capital Sec. Pvt Ltd
    21 Shakil Niwas,
    Mahakali Caves Road,Andheri (E)
    Mumbai - Mumbai - 400 093

Hikal Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hikal 317.20 1,787.05 1,784.60 43.04 7.51
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10